## Monitoring the progression of hepatitis C virus (HCV ) includes clinical, biochemical, and histological parameters. Quantitation of viral load by reverse-transcription polymerase chain reaction (RT-PCR) may offer a more reliable marker of disease status. Conflicting reports on viral titers may
Natural fluctuations of hepatitis C viral load in a homogeneous patient population: A prospective study
β Scribed by Liam Fanning; Elizabeth Kenny-Walsh; John Levis; Kingshuk Roy Choudhury; Bridin Cannon; Margaret Sheehan; Michael Whelton; Fergus Shanahan
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 156 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
The study group defined here is part of a previously wellcharacterized cohort of women infected with HCV 1b-contaminated Abbreviations: HCV, hepatitis C virus; RT-PCR, reverse transcription polymerase chain reaction.
π SIMILAR VOLUMES
## Abstract The distributions of the different genotypes of the hepatitis C virus (HCV) and GBVβC virus (GBVβC/HGV) vary geographically and information worldwide is still incomplete. In particular, there are few data on the distribution of genotypes (and their relationship to the severity of liver
We examined the feasibility of hepatitis C treatment in patients on opioid maintenance. One hundred patients with chronic hepatitis C, 50 on methadone maintenance, and 50 with no intravenous drug use or opioid maintenance for at least 5 years were prospectively matched for sex, age, hepatitis C viru
## It is widely thought, but not yet explained, that there might be a pathogenetic link between the infection of hepatitis C virus (HCV) and the onset of B non-Hodgkin's lymphoma (NHL). We studied the prevalence of serum anti-HCV antibodies among 300 NHL comparing it with the prevalence among 600 a
## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first